Cholesteryl ester storage disease (CESD) is a rare genetic disorder caused by homozygous or compound heterozygous pathogenic variants in the lipase A (LIPA) gene encoding lysosomal acid lipase (LAL). LAL deficiency is characterized by progressive accumulation of cholesteryl esters in hepatocytes and macrophages, ultimately leading to organ damage and potentially hepatic failure. Here we describe a girl with biochemistry similar to familial hypercholesterolaemia (FH) having a total cholesterol of 9.3 mmol/L, low-density lipoprotein cholesterol of 7.1 mmol/L, triglycerides of 2.7 mmol/L, and alanine transaminase of 354 U/L. Whole genome sequencing found her to be compound heterozygous for NM_000235.4:c.894G>A p.(Gln298=) and NM_000235.4:c.419G>A p.(Trp140*) in the LIPA gene, consistent with the diagnosis compound heterozygous CESD. The patient had no clinical signs of cholesterol deposits and no symptoms suggestive of organ damage. This case report highlights the difficulties in diagnosing a rare subclinical disease with similarities to FH followed by discussion of current treatment options.
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269